Australian Clinical Labs Limited

ACL.ASX

Health Care

Provision of pathology services

Market Data

Price

$2.330

-0.0%
Market Cap

$434.6M

P/E Ratio

16.1x

EPS

$0.145

Div. Yield

5.47%

52-Week Change

-0.0%

Recent Announcements

13 Jul 2026 Sph Neutral

Ceasing to be a substantial holder

Citigroup Global Markets Australia Pty Limited (ACN 003 114 832) ceased to be a substantial holder.

9 Jul 2026 Sph Neutral

Becoming a substantial holder

Citigroup Global Markets Australia Pty Limited (ACN 003 114 832) became a substantial holder (5.0163%).

2 Jul 2026 Sph Neutral

Ceasing to be a substantial holder

Citigroup Global Markets Australia Pty Limited (ACN 003 114 832) ceased to be a substantial holder.

9 Jun 2026 Sph Neutral

Becoming a substantial holder

Citigroup Global Markets Australia Pty Limited (ACN 003 114 832) became a substantial holder (5.0052%).

8 May 2026 Sph Neutral

Ceasing to be a substantial holder

Franklin Resources, Inc., and its affiliates ceased to be a substantial holder.

4 May 2026 Sph Neutral

Ceasing to be a substantial holder from MQG

MQG ceased to be a substantial holder.

27 Apr 2026 Sph Neutral

Becoming a substantial holder from MQG

MQG became a substantial holder (5.11%).

17 Apr 2026 Sph Neutral

Ceasing to be a substantial holder

United Super Pty Ltd ceased to be a substantial holder.

16 Apr 2026 Sph Neutral

Becoming a substantial holder

Australian Retirement Trust Pty LTD ATF Australian Retirement Trust became a substantial holder (5.003%).

8 Apr 2026 Sph Neutral

Ceasing to be a substantial holder from MQG

MQG ceased to be a substantial holder.

Get real-time alerts for ACL

Receive AI-powered earnings summaries and instant notifications when Australian Clinical Labs Limited releases results.

Register Free